Pharmaceutical & Life Sciences News

Senators Vow Congressional Action to End Drug Patent Abuse

Feb. 26, 2019, 7:13 PM

Republican members of the Senate Judiciary Committee are threatening legislation to prevent drug companies from gaming the patent system to extend market exclusivity for blockbuster drugs.

GOP Sen. John Cornyn of Texas, who sits on the panel, today said he plans to speak to other Judiciary Committee members about how to stop companies from unfairly extending drug patents.

He made the remarks after questioning AbbVie CEO Richard Gonzalez during a Senate Finance hearing on drug prices about the roughly 130 patents the company held for its drug Humira.

Finance Committee Chairman Chuck Grassley of Iowa, also a member of the...

To read the full article log in. To learn more about a subscription click here.